Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
39M
-
Shares change
-
+3.42M
-
Total reported value, excl. options
-
$327M
-
Value change
-
+$24.7M
-
Put/Call ratio
-
1.46
-
Number of buys
-
74
-
Number of sells
-
-57
-
Price
-
$8.39
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q2 2023
163 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2023.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
of 60M outstanding shares and own 65.02% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.4M shares), BlackRock Inc. (3.23M shares), VANGUARD GROUP INC (3.18M shares), STATE STREET CORP (3.04M shares), Knoll Capital Management, LLC (3.02M shares), DIMENSIONAL FUND ADVISORS LP (1.13M shares), EAGLE ASSET MANAGEMENT INC (1.06M shares), Laurion Capital Management LP (1M shares), GEODE CAPITAL MANAGEMENT, LLC (953K shares), and Verition Fund Management LLC (930K shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.